Status:
COMPLETED
Noninvasive Brain Stimulation in Mild Cognitive Impairment and Dementia
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Alzheimer Disease
Mild Cognitive Impairment
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The research objective of this study is to examine the efficacy of HD-tDCS to the preSMA/DACC region and its influence on verbal episodic memory in patients with MCI or dementia after 10 sessions of H...
Detailed Description
This is a pilot study being done to attempt to improve verbal episodic memory in persons with mild cognitive impairment (MCI) and dementia. Although the hippocampus is a brain structure most often ass...
Eligibility Criteria
Inclusion
- Age 50 and older
- Fluent in English
- Active diagnosis of MCI or dementia
Exclusion
- Substance use disorder
- Has metal fragments in head
- Taking medications that may interact with the HD-tDCS effect (i.e., amphetamines, L-dopa, carbamazepine, sulpiride, pergolide, lorazepam, dextromethorphan, D-cycloserine, flunarizine, or ropinirole)
Key Trial Info
Start Date :
July 13 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 15 2024
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT05270408
Start Date
July 13 2022
End Date
February 15 2024
Last Update
March 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT Southwestern Medical Center
Dallas, Texas, United States, 75390